Boström Gustaf, Hörnsten Carl, Brännström Jon, Conradsson Mia, Nordström Peter, Allard Per, Gustafson Yngve, Littbrand Håkan
Department of Community Medicine and Rehabilitation,Geriatric Medicine,Umeå University,Umeå,Sweden.
Department of Clinical Sciences,Division of Psychiatry,Umeå University,Umeå,Sweden.
Int Psychogeriatr. 2016 Jul;28(7):1201-10. doi: 10.1017/S104161021600048X. Epub 2016 Mar 18.
Antidepressant treatment may increase the risk of death. The association between antidepressants and mortality has been evaluated in community-dwelling older people, but not in representative samples of very old people, among whom dementia, multimorbidity, and disability are common.
Umeå 85+/GERDA study participants (n = 992) aged 85, 90, and ≥95 years were followed for up to five years. Cox proportional hazard regression models were used to analyze mortality risk associated with baseline antidepressant treatment, adjusted for potential confounders.
Mean age was 89 years; 27% of participants had dementia, 20% had stroke histories, 29% had heart failure, and 16% used antidepressants. In age- and sex-adjusted analyses, antidepressant use was associated with a 76% increased mortality risk (hazard ratio [HR] = 1.76; 95% confidence interval [CI], 1.41-2.19). Adding adjustment for Geriatric Depression Scale score, HR was 1.62 (95% CI, 1.29-2.03). The association was not significant when adjusting for additional confounding factors (HR = 1.08; 95% CI, 0.85-1.38). Interaction analyses in the fully adjusted model revealed a significant interaction between sex and antidepressant use (HR: 1.76; 95% CI, 1.05-2.94). Among male and female antidepressant users, the HRs for death were 0.76 (95% CI, 0.47-1.24) and 1.28 (95% CI, 0.97-1.70), respectively.
Among very old people, baseline antidepressant treatment does not seem to be independently associated with increased mortality risk. However, the risk may be different in men and women. This difference and the potential risk of initial treatment require further investigation in future cohort studies of very old people.
抗抑郁治疗可能会增加死亡风险。抗抑郁药与死亡率之间的关联已在社区居住的老年人中进行了评估,但在非常老年人的代表性样本中尚未评估,这些老年人中痴呆、多种疾病和残疾很常见。
对乌梅奥85岁以上/德国老年抑郁纵向研究(GERDA)中年龄为85岁、90岁和≥95岁的992名参与者进行了长达五年的随访。使用Cox比例风险回归模型分析与基线抗抑郁治疗相关的死亡风险,并对潜在混杂因素进行了调整。
平均年龄为89岁;27%的参与者患有痴呆,20%有中风病史,29%有心力衰竭,16%使用抗抑郁药。在年龄和性别调整分析中,使用抗抑郁药与死亡风险增加76%相关(风险比[HR]=1.76;95%置信区间[CI],1.41 - 2.19)。加入老年抑郁量表评分进行调整后,HR为1.62(95%CI,1.29 - 2.03)。在调整其他混杂因素后,该关联不显著(HR = 1.08;95%CI,0.85 - 1.38)。在完全调整模型中的交互分析显示,性别与抗抑郁药使用之间存在显著交互作用(HR:1.76;95%CI,1.05 - 2.94)。在男性和女性抗抑郁药使用者中,死亡的HR分别为0.76(95%CI,0.47 - 1.24)和1.28(95%CI,0.97 - 1.70)。
在非常老年人中,基线抗抑郁治疗似乎与死亡风险增加没有独立关联。然而,男性和女性的风险可能不同。这种差异以及初始治疗的潜在风险需要在未来针对非常老年人的队列研究中进一步调查。